Brief: Phasebio Reports Q4 And FY20 Financial Results

PhaseBio Pharmaceuticals

15/03/2021 12:11

March 15 (Reuters) - PhaseBio Pharmaceuticals Inc  PHAS.O :
    * PHASEBIO REPORTS FOURTH-QUARTER AND FULL-YEAR 2020
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
    * QTRLY LOSS PER SHARE $1.03
    * Q4 EARNINGS PER SHARE VIEW $-0.71 -- REFINITIV IBES DATA
    * CASH AND CASH EQUIVALENTS AT DEC 31, 2020 WERE $28.1
MILLION
VERSUS $74.0 MILLION AT DEC 31, 2019

Source text for Eikon:  ID:nBw1L8vP8a 
Further company coverage:  PHAS.O 

 ((Reuters.Briefs@thomsonreuters.com;))